Загрузка видео...

Не удалось загрузить видео

На главную

🚨 “THE BEST RESULTS I’VE SEEN.” DR. WILLIAM MAKIS & DR. JOHN CAMPBELL DISCUSS IVERMECTIN + CHEMOTHERAPY FOR CANCER What happens when Dr. John Campbell asks Dr. William Makis to get specific about Ivermectin and cancer? The conversation quickly moves from theory to dose, timeline, cancer markers, imaging, and...

rxmeds_store's profile picture

RXMEDS.STORE

13,317 subscribers

25,194 просмотров • 9 дней назад •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

Комментарии: 5

Фото профиля Edward Hinge
Edward Hinge9 дней назад

💯 🙌

Фото профиля Nicolas de Cues
Nicolas de Cues8 дней назад

How about and keto & fasting? How about high intensity exercise? How about sauna / ice baths? How about high dose IV vitamin C? How about other micronutrients, mg, vit D3, etc.?

Фото профиля Ronald Palacios
Ronald Palacios8 дней назад

No scientific double blind studies testing ivermectin alone or together with other drugs available.just anecdotal reports.t much publicity by the same groups though.

Фото профиля יעל_שליכטינג
יעל_שליכטינג8 дней назад

I wouldn’t reject am mild chemo therapy, but just as indifferentiated as this guy suggests would be off limits for me.

Фото профиля T Grogan
T Grogan8 дней назад

Why isn't Makis in jail? How can he still practice? His advice is going to get people killed. Scum.

Похожие видео

🚨 DR. WILLIAM MAKIS SAYS THIS IS THE MOST IMPORTANT IVERMECTIN DOSING GRAPH HE'S CREATED. Not a new chemotherapy drug. Not a breakthrough immunotherapy. Not a billion-dollar cancer treatment. Just one simple dosing strategy. According to Dr. William Makis, this is the dosing framework he believes everyone researching repurposed medicines for cancer should understand first. And it all starts with one number. 📌 1 mg/kg/day. Before explaining why, here's the dosing framework Dr. Makis discusses. 📊 The Four Ivermectin Dosing Ranges 🟢 Low Dose: ≤0.5 mg/kg/day Used for cancers in remission, strong family history, genetic predisposition, prophylaxis, and lower-dose protocols discussed in published case reports. 🟡 Medium Dose: 1.0 mg/kg/day Dr. Makis' recommended starting dose for most cancers. 🔵 High Dose: 2.0 mg/kg/day Discussed for very aggressive cancers, including leukaemia, pancreatic cancer, and some brain cancers. 🔴 Very High Dose: ≥2.5 mg/kg/day Discussed in selected reported cases involving extensive metastatic disease or extremely poor prognosis, where temporary visual side effects have also been reported. Now here's why Dr. Makis believes 1 mg/kg/day deserves the most attention. After reviewing laboratory research, published studies, and numerous case reports, he says this is the starting dose he recommends for most cancers. According to Dr. Makis, research has investigated Ivermectin across a surprisingly wide range of cancers, including: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Kidney (renal cell) cancer • Gastric cancer • Leukemia One exception stood out. Lymphoma. Dr. Makis says he has found very little published research involving Ivermectin and lymphoma. That doesn't mean it doesn't work. It simply means the evidence is currently limited. ❓What does 1 mg/kg/day actually look like? For someone weighing 60 kg (132 lbs)... That's approximately 60 mg of Ivermectin every day. Equivalent to: 💊 Five 12 mg tablets OR 💧 About 6 mL of liquid Ivermectin, roughly one teaspoon. According to Dr. Makis, that's where he recommends starting for many cancers. Can lower doses still have an effect? ✅ He believes they can. Dr. Makis discusses a published ovarian cancer case reported by Dr. Tess Lawrie. The dosing chart lists the patient as receiving 12 mg of Ivermectin per day. During his discussion, Dr. Makis explains that this was approximately 0.2 mg/kg/day, placing it within the chart's Low Dose (≤0.5 mg/kg/day) range. 📉 According to the case report, the patient's CA125 tumor marker reportedly fell from 288 to 22 after two months. That case is one reason Dr. Makis believes Ivermectin may have anticancer activity even at lower doses. However... He also believes the available evidence suggests the effect is dose dependent. In other words... Higher doses may produce greater effects, although more clinical research is needed. What about the most aggressive cancers? • Pancreatic cancer • Leukemia • Brain cancer For cancers like these, Dr. Makis discusses doses around 2 mg/kg/day in selected situations. He notes that Ivermectin crosses the blood-brain barrier, although not very efficiently, which is one reason he says higher doses may be considered for some brain cancers. He also discusses a case reported by Dr. Allan Landrito. According to Dr. Makis, a physician with terminal gallbladder cancer reportedly took 2 mg/kg/day for 14 months. He says her cancer eventually disappeared. She experienced temporary visual side effects that resolved after a few days. ❓How high have reported doses gone? According to Dr. Makis, he has seen reported doses as high as 2.5 mg/kg/day. He references patients treated by Dr. Shankara Chetty who reportedly used those doses without long-term side effects, although some experienced temporary visual disturbances that later resolved. One point Dr. Makis returns to repeatedly... Long-term use. He references the Castro study involving children with leukemia who reportedly received Ivermectin for six months without long-term side effects. He also discusses anecdotal reports of adults taking it daily for more than a year without long-term toxicity. So why aren't there larger cancer trials? Dr. Makis believes one of the biggest obstacles is economics. Because Ivermectin is an off-patent generic medicine, he argues there is little financial incentive to fund large clinical trials. Whether future research ultimately confirms or challenges these ideas remains to be seen. But Dr. Makis' message is remarkably simple. One graph. One dosing strategy. One starting point. 📌 1 mg/kg/day. Because the conversation isn't just about Ivermectin anymore. It's about whether repurposed drugs deserve the same level of scientific investigation as newer therapies. 🗨️ Do you think inexpensive repurposed medicines like Ivermectin deserve larger, well-designed clinical trials for cancer? 🔖 Save this post so you'll always have Dr. Makis' dosing framework handy, and repost it to help others discover the ongoing research into repurposed medicines. 💊 Looking for pharmaceutical grade Ivermectin, Fenbendazole, or Mebendazole? Choose RXMEDS.STORE. Trusted by thousands of customers worldwide. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #CancerCare #MedicalResearch #PancreaticCancer #MakisMD #RxMeds
5:47

🚨 DR. WILLIAM MAKIS SAYS THIS IS THE MOST IMPORTANT IVERMECTIN DOSING GRAPH HE'S CREATED. Not a new chemotherapy drug. Not a breakthrough immunotherapy. Not a billion-dollar cancer treatment. Just one simple dosing strategy. According to Dr. William Makis, this is the dosing framework he believes everyone researching repurposed medicines for cancer should understand first. And it all starts with one number. 📌 1 mg/kg/day. Before explaining why, here's the dosing framework Dr. Makis discusses. 📊 The Four Ivermectin Dosing Ranges 🟢 Low Dose: ≤0.5 mg/kg/day Used for cancers in remission, strong family history, genetic predisposition, prophylaxis, and lower-dose protocols discussed in published case reports. 🟡 Medium Dose: 1.0 mg/kg/day Dr. Makis' recommended starting dose for most cancers. 🔵 High Dose: 2.0 mg/kg/day Discussed for very aggressive cancers, including leukaemia, pancreatic cancer, and some brain cancers. 🔴 Very High Dose: ≥2.5 mg/kg/day Discussed in selected reported cases involving extensive metastatic disease or extremely poor prognosis, where temporary visual side effects have also been reported. Now here's why Dr. Makis believes 1 mg/kg/day deserves the most attention. After reviewing laboratory research, published studies, and numerous case reports, he says this is the starting dose he recommends for most cancers. According to Dr. Makis, research has investigated Ivermectin across a surprisingly wide range of cancers, including: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Kidney (renal cell) cancer • Gastric cancer • Leukemia One exception stood out. Lymphoma. Dr. Makis says he has found very little published research involving Ivermectin and lymphoma. That doesn't mean it doesn't work. It simply means the evidence is currently limited. ❓What does 1 mg/kg/day actually look like? For someone weighing 60 kg (132 lbs)... That's approximately 60 mg of Ivermectin every day. Equivalent to: 💊 Five 12 mg tablets OR 💧 About 6 mL of liquid Ivermectin, roughly one teaspoon. According to Dr. Makis, that's where he recommends starting for many cancers. Can lower doses still have an effect? ✅ He believes they can. Dr. Makis discusses a published ovarian cancer case reported by Dr. Tess Lawrie. The dosing chart lists the patient as receiving 12 mg of Ivermectin per day. During his discussion, Dr. Makis explains that this was approximately 0.2 mg/kg/day, placing it within the chart's Low Dose (≤0.5 mg/kg/day) range. 📉 According to the case report, the patient's CA125 tumor marker reportedly fell from 288 to 22 after two months. That case is one reason Dr. Makis believes Ivermectin may have anticancer activity even at lower doses. However... He also believes the available evidence suggests the effect is dose dependent. In other words... Higher doses may produce greater effects, although more clinical research is needed. What about the most aggressive cancers? • Pancreatic cancer • Leukemia • Brain cancer For cancers like these, Dr. Makis discusses doses around 2 mg/kg/day in selected situations. He notes that Ivermectin crosses the blood-brain barrier, although not very efficiently, which is one reason he says higher doses may be considered for some brain cancers. He also discusses a case reported by Dr. Allan Landrito. According to Dr. Makis, a physician with terminal gallbladder cancer reportedly took 2 mg/kg/day for 14 months. He says her cancer eventually disappeared. She experienced temporary visual side effects that resolved after a few days. ❓How high have reported doses gone? According to Dr. Makis, he has seen reported doses as high as 2.5 mg/kg/day. He references patients treated by Dr. Shankara Chetty who reportedly used those doses without long-term side effects, although some experienced temporary visual disturbances that later resolved. One point Dr. Makis returns to repeatedly... Long-term use. He references the Castro study involving children with leukemia who reportedly received Ivermectin for six months without long-term side effects. He also discusses anecdotal reports of adults taking it daily for more than a year without long-term toxicity. So why aren't there larger cancer trials? Dr. Makis believes one of the biggest obstacles is economics. Because Ivermectin is an off-patent generic medicine, he argues there is little financial incentive to fund large clinical trials. Whether future research ultimately confirms or challenges these ideas remains to be seen. But Dr. Makis' message is remarkably simple. One graph. One dosing strategy. One starting point. 📌 1 mg/kg/day. Because the conversation isn't just about Ivermectin anymore. It's about whether repurposed drugs deserve the same level of scientific investigation as newer therapies. 🗨️ Do you think inexpensive repurposed medicines like Ivermectin deserve larger, well-designed clinical trials for cancer? 🔖 Save this post so you'll always have Dr. Makis' dosing framework handy, and repost it to help others discover the ongoing research into repurposed medicines. 💊 Looking for pharmaceutical grade Ivermectin, Fenbendazole, or Mebendazole? Choose RXMEDS.STORE. Trusted by thousands of customers worldwide. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #CancerCare #MedicalResearch #PancreaticCancer #MakisMD #RxMeds

RXMEDS.STORE

363,479 просмотров • 2 месяцев назад

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)
22:06

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)

The Vigilant Fox 🦊

1,292,906 просмотров • 1 год назад

🚨Dr. William Makis: Ivermectin Dosing for Cancer Explained In one of his recent talks, Dr. William Makis shared what he considers the most important dosing guide for using Ivermectin in cancer. According to Dr. Makis, the starting dose for most cancers is 1 mg per kilogram of body weight per day For example, a person weighing 60 kg would take 60 mg daily, that’s five 12 mg pills or roughly one teaspoon (6 ml) of liquid ivermectin. He mentioned that Ivermectin has shown positive effects in many types of cancer, including: - Breast cancer - Colon cancer - Lung cancer - Pancreatic cancer - Gastric cancer - Renal cell carcinoma - Leukemias He noted that there is very little research on lymphomas, but that doesn’t mean it won’t work, it simply hasn’t been studied much yet. Important points from Dr. Makis: 1) The anti-cancer effect of Ivermectin appears to be dose dependent. 2) Higher doses may offer better results in more aggressive cancers. 3) For very aggressive cancers (such as pancreatic, leukemia, or brain cancers), he suggests considering 2 mg/kg or even up to 2.5 mg/kg per day. Some patients have used these higher doses for many months with only temporary side effects (such as mild visual disturbances that usually resolve within a few days). Real-world examples include a prostate cancer patient whose PSA dropped from 89 to 11 on 45 mg daily, and a terminal gallbladder cancer case that resolved after 14 months on 2 mg/kg. Dr. Makis emphasizes that Ivermectin is a very safe drug with no reported long-term side effects at 1 mg/kg. He recommends starting at this dose and adjusting upwards depending on the individual case and cancer type. He also stresses that people can safely stay on Ivermectin for months as long as there is active disease. If you're researching Ivermectin for cancer protocols, many people are choosing GENIX MEDS for clean, pharmaceutical-grade Ivermectin with straightforward worldwide delivery. #Ivermectindosage #MakisMD #Genixmeds
5:47

🚨Dr. William Makis: Ivermectin Dosing for Cancer Explained In one of his recent talks, Dr. William Makis shared what he considers the most important dosing guide for using Ivermectin in cancer. According to Dr. Makis, the starting dose for most cancers is 1 mg per kilogram of body weight per day For example, a person weighing 60 kg would take 60 mg daily, that’s five 12 mg pills or roughly one teaspoon (6 ml) of liquid ivermectin. He mentioned that Ivermectin has shown positive effects in many types of cancer, including: - Breast cancer - Colon cancer - Lung cancer - Pancreatic cancer - Gastric cancer - Renal cell carcinoma - Leukemias He noted that there is very little research on lymphomas, but that doesn’t mean it won’t work, it simply hasn’t been studied much yet. Important points from Dr. Makis: 1) The anti-cancer effect of Ivermectin appears to be dose dependent. 2) Higher doses may offer better results in more aggressive cancers. 3) For very aggressive cancers (such as pancreatic, leukemia, or brain cancers), he suggests considering 2 mg/kg or even up to 2.5 mg/kg per day. Some patients have used these higher doses for many months with only temporary side effects (such as mild visual disturbances that usually resolve within a few days). Real-world examples include a prostate cancer patient whose PSA dropped from 89 to 11 on 45 mg daily, and a terminal gallbladder cancer case that resolved after 14 months on 2 mg/kg. Dr. Makis emphasizes that Ivermectin is a very safe drug with no reported long-term side effects at 1 mg/kg. He recommends starting at this dose and adjusting upwards depending on the individual case and cancer type. He also stresses that people can safely stay on Ivermectin for months as long as there is active disease. If you're researching Ivermectin for cancer protocols, many people are choosing GENIX MEDS for clean, pharmaceutical-grade Ivermectin with straightforward worldwide delivery. #Ivermectindosage #MakisMD #Genixmeds

GENIX MEDS

20,168 просмотров • 3 месяцев назад

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD
4:38

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD

RXMEDS.STORE

18,224 просмотров • 1 месяц назад

🚨 DR WILLIAM MAKIS: “THE CANCER BREAKTHROUGH THEY DON’T WANT TO TALK ABOUT” Oncologist Dr William Makis dropped a bombshell on The Shannon Joy Show — revealing what decades of cancer research have missed. “Antiparasitics have a dozen mechanisms of action… ivermectin goes after cancer stem cells… fenbendazole and mebendazole shut down glucose transporters — starving the tumor of fuel.” According to Dr Makis, chemo alone kills only the rapidly dividing cells — leaving cancer stem cells alive to spread years later. But add ivermectin, he says, and those hidden cells are targeted too — reversing resistance and triggering “tumor shrinkage oncologists have never seen.” 400+ studies now explore ivermectin’s potential role in cancer treatment — yet mainstream medicine remains silent. Could cheap, repurposed antiparasitics threaten the trillion-dollar cancer industry? Dr Makis thinks so. And he’s not backing down. Shannon Joy
3:31

🚨 DR WILLIAM MAKIS: “THE CANCER BREAKTHROUGH THEY DON’T WANT TO TALK ABOUT” Oncologist Dr William Makis dropped a bombshell on The Shannon Joy Show — revealing what decades of cancer research have missed. “Antiparasitics have a dozen mechanisms of action… ivermectin goes after cancer stem cells… fenbendazole and mebendazole shut down glucose transporters — starving the tumor of fuel.” According to Dr Makis, chemo alone kills only the rapidly dividing cells — leaving cancer stem cells alive to spread years later. But add ivermectin, he says, and those hidden cells are targeted too — reversing resistance and triggering “tumor shrinkage oncologists have never seen.” 400+ studies now explore ivermectin’s potential role in cancer treatment — yet mainstream medicine remains silent. Could cheap, repurposed antiparasitics threaten the trillion-dollar cancer industry? Dr Makis thinks so. And he’s not backing down. Shannon Joy

Commentary | Global Ivermectin Research Hub

2,324,509 просмотров • 10 месяцев назад

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds
3:32

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds

RXMEDS.STORE

16,612 просмотров • 3 месяцев назад

🚨 “LOW TO VERY HIGH DOSES.” DR. WILLIAM MAKIS’ IVERMECTIN PROTOCOL FOR PARASITES, CANCER, FAMILY HISTORY & NEUROLOGICAL CONDITIONS Ivermectin is best known as an antiparasitic medicine. But Dr. William Makis discusses a much broader range of potential applications, including Parkinson’s disease, Alzheimer’s disease and cancer-related protocols. The accompanying Ivermectin protocol graphic organizes his reported dosing framework into four tiers. 📋 Ivermectin dosage framework shown in the chart Ivermectin Dosage Guide 🟢 LOW Anti-parasitic: 0.0267 g/kg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days Cancer remission: 222 mg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days Family history: 444 mg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days 🟡 MEDIUM Anti-parasitic / most cancers: 0.0535 g/kg • 6 days on, 1 day off • Until remission • Minimum 3 months Cancer: 444 mg • 6 days on, 1 day off • Until remission • Minimum 3 months 🔵 HIGH Aggressive cancers: 0.1070 g/kg • 6 days on, 1 day off • Until remission Leukemia, pancreatic, brain: 888–1,000 mg split doses • 6 days on, 1 day off • Until remission 🔴 VERY HIGH Terminal, metastatic cancers: 0.1337 g/kg • 6 days on, 1 day off • Short term Cancer: 1,500 mg split doses • 6 days on, 1 day off • Maximum 5 days ⚠️ Do not start any treatment without guidance from a doctor or qualified physician. 🧠 Then comes the neurological angle Makis says the neurological conditions where he has seen what he describes as the most success are: Parkinson’s disease + Alzheimer’s disease 1️⃣ Parkinson’s disease Makis describes cases involving what he calls high-dose Ivermectin, specifically mentioning: 60 mg → 72 mg He reports improvements in: • Movement • Mobility • Symptoms One patient he describes was barely mobile despite maximum standard treatment. After several weeks of high-dose Ivermectin, he says the patient started playing golf again, despite having been unable to play for years. He also says he has seen what he describes as reversal in a number of Parkinson’s patients. 2️⃣ Alzheimer’s disease This is where Makis says the stories became even more striking. He describes families reporting that elderly patients: • Recognized relatives again • Remembered people they had not recognized for years • Started reminiscing • Recalled old memories • Showed improved cognitive ability For these cases, he specifically discusses: 12 mg → 24 mg of Ivermectin He describes these amounts being used for several days in the cases he discusses. One particularly striking account involves a patient who was reportedly taken off hospice after improving. And the family reaction? “My grandma’s back.” Antiparasitic conditions. Cancer remission. Family history. Aggressive cancers. Metastatic cancers. Parkinson’s disease. Alzheimer’s disease. Different conditions. Different reported applications. Different reported dosing approaches. But one medicine: 💊 Ivermectin. 🔥 The breadth of the discussion is hard to ignore From an established antiparasitic medicine to reported applications involving cancer, Parkinson’s and Alzheimer’s, Ivermectin is now part of a much broader research conversation. Different conditions. Different reported experiences. One medicine generating very different questions across medicine. From antiparasitic protocols to reported cancer applications, Parkinson’s and Alzheimer’s cases, this video + protocol chart covers a lot. 🗨️ Which area deserves the most research attention: cancer, Parkinson’s, Alzheimer’s, parasites, or something else? 🔖 SAVE this post so you have Ivermectin dosing framework and the full video discussion handy. 🔄 REPOST to help others discover the broader research and clinical discussions surrounding Ivermectin. 💊 Looking for Ivermectin? Discover available options at RXMEDS.STORE with worldwide delivery. #Ivermectin #CancerResearch #Parkinsons #Alzheimers #Neurology #RepurposedMedicine #MakisMD #RxMeds
3:57

🚨 “LOW TO VERY HIGH DOSES.” DR. WILLIAM MAKIS’ IVERMECTIN PROTOCOL FOR PARASITES, CANCER, FAMILY HISTORY & NEUROLOGICAL CONDITIONS Ivermectin is best known as an antiparasitic medicine. But Dr. William Makis discusses a much broader range of potential applications, including Parkinson’s disease, Alzheimer’s disease and cancer-related protocols. The accompanying Ivermectin protocol graphic organizes his reported dosing framework into four tiers. 📋 Ivermectin dosage framework shown in the chart Ivermectin Dosage Guide 🟢 LOW Anti-parasitic: 0.0267 g/kg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days Cancer remission: 222 mg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days Family history: 444 mg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days 🟡 MEDIUM Anti-parasitic / most cancers: 0.0535 g/kg • 6 days on, 1 day off • Until remission • Minimum 3 months Cancer: 444 mg • 6 days on, 1 day off • Until remission • Minimum 3 months 🔵 HIGH Aggressive cancers: 0.1070 g/kg • 6 days on, 1 day off • Until remission Leukemia, pancreatic, brain: 888–1,000 mg split doses • 6 days on, 1 day off • Until remission 🔴 VERY HIGH Terminal, metastatic cancers: 0.1337 g/kg • 6 days on, 1 day off • Short term Cancer: 1,500 mg split doses • 6 days on, 1 day off • Maximum 5 days ⚠️ Do not start any treatment without guidance from a doctor or qualified physician. 🧠 Then comes the neurological angle Makis says the neurological conditions where he has seen what he describes as the most success are: Parkinson’s disease + Alzheimer’s disease 1️⃣ Parkinson’s disease Makis describes cases involving what he calls high-dose Ivermectin, specifically mentioning: 60 mg → 72 mg He reports improvements in: • Movement • Mobility • Symptoms One patient he describes was barely mobile despite maximum standard treatment. After several weeks of high-dose Ivermectin, he says the patient started playing golf again, despite having been unable to play for years. He also says he has seen what he describes as reversal in a number of Parkinson’s patients. 2️⃣ Alzheimer’s disease This is where Makis says the stories became even more striking. He describes families reporting that elderly patients: • Recognized relatives again • Remembered people they had not recognized for years • Started reminiscing • Recalled old memories • Showed improved cognitive ability For these cases, he specifically discusses: 12 mg → 24 mg of Ivermectin He describes these amounts being used for several days in the cases he discusses. One particularly striking account involves a patient who was reportedly taken off hospice after improving. And the family reaction? “My grandma’s back.” Antiparasitic conditions. Cancer remission. Family history. Aggressive cancers. Metastatic cancers. Parkinson’s disease. Alzheimer’s disease. Different conditions. Different reported applications. Different reported dosing approaches. But one medicine: 💊 Ivermectin. 🔥 The breadth of the discussion is hard to ignore From an established antiparasitic medicine to reported applications involving cancer, Parkinson’s and Alzheimer’s, Ivermectin is now part of a much broader research conversation. Different conditions. Different reported experiences. One medicine generating very different questions across medicine. From antiparasitic protocols to reported cancer applications, Parkinson’s and Alzheimer’s cases, this video + protocol chart covers a lot. 🗨️ Which area deserves the most research attention: cancer, Parkinson’s, Alzheimer’s, parasites, or something else? 🔖 SAVE this post so you have Ivermectin dosing framework and the full video discussion handy. 🔄 REPOST to help others discover the broader research and clinical discussions surrounding Ivermectin. 💊 Looking for Ivermectin? Discover available options at RXMEDS.STORE with worldwide delivery. #Ivermectin #CancerResearch #Parkinsons #Alzheimers #Neurology #RepurposedMedicine #MakisMD #RxMeds

RXMEDS.STORE

14,786 просмотров • 3 дней назад

🚨 THE IVERMECTIN DOSING CHART EVERYONE'S SHARING 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). 🟢 LOW DOSE (≤ 0.5 mg/kg/day) Often discussed for: • Remission support • Prevention strategies • Strong family history of cancer 🟡 MEDIUM DOSE (1.0 mg/kg/day) Most commonly discussed for: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Renal cancers • Gastric cancers This is the dose Dr. Makis frequently references as a starting point in cancer discussions. 🔴 HIGH DOSE (2.0 mg/kg/day) Often discussed for: • Leukemia • Brain cancers • Pancreatic cancers • Other highly aggressive cancers 🔴 VERY HIGH DOSE (≥ 2.5 mg/kg/day) Typically discussed only in: • Advanced metastatic disease • Extremely aggressive cancers • Situations where patients have exhausted conventional options For a 60 kg (132 lb) person: • Low Dose: ≤30 mg/day • Medium Dose: 60 mg/day • High Dose: 120 mg/day • Very High Dose: ≥150 mg/day The reason this chart keeps getting shared isn't because everyone agrees with it. It's because millions of people are now asking a question they never asked before: That's why the conversation around repurposed medicines keeps getting bigger. If you want access to ivermectin, fenbendazole, or mebendazole, then visit PharmacyinUSA today!
5:47

🚨 THE IVERMECTIN DOSING CHART EVERYONE'S SHARING 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). 🟢 LOW DOSE (≤ 0.5 mg/kg/day) Often discussed for: • Remission support • Prevention strategies • Strong family history of cancer 🟡 MEDIUM DOSE (1.0 mg/kg/day) Most commonly discussed for: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Renal cancers • Gastric cancers This is the dose Dr. Makis frequently references as a starting point in cancer discussions. 🔴 HIGH DOSE (2.0 mg/kg/day) Often discussed for: • Leukemia • Brain cancers • Pancreatic cancers • Other highly aggressive cancers 🔴 VERY HIGH DOSE (≥ 2.5 mg/kg/day) Typically discussed only in: • Advanced metastatic disease • Extremely aggressive cancers • Situations where patients have exhausted conventional options For a 60 kg (132 lb) person: • Low Dose: ≤30 mg/day • Medium Dose: 60 mg/day • High Dose: 120 mg/day • Very High Dose: ≥150 mg/day The reason this chart keeps getting shared isn't because everyone agrees with it. It's because millions of people are now asking a question they never asked before: That's why the conversation around repurposed medicines keeps getting bigger. If you want access to ivermectin, fenbendazole, or mebendazole, then visit PharmacyinUSA today!

PharmacyinUSA

51,352 просмотров • 3 месяцев назад

🚨 “THIS WAS NEVER MEANT TO BE SEEN.” In a viral interview, William Makis says cancer research may have overlooked something big. Repurposed antiparasitics are getting serious attention. Here’s what he points to 👇 • Ivermectin may target cancer stem cells that chemo struggles to reach. • Fenbendazole and Mebendazole may interfere with tumor energy pathways. • Drug resistance could potentially be reduced. • Tumor shrinkage has been reported in difficult cases. The conversation around Anti-parasitic medicines is growing fast and patients need to know more. Follow us because we provide this type of information everyday! Visit our profile PharmacyinUSA to find these meds 🙌🏻 #Ivermectin #Fenbendazole #Mebendazole #Cancercure #MakisMD #PharmacyinUSA
3:31

🚨 “THIS WAS NEVER MEANT TO BE SEEN.” In a viral interview, William Makis says cancer research may have overlooked something big. Repurposed antiparasitics are getting serious attention. Here’s what he points to 👇 • Ivermectin may target cancer stem cells that chemo struggles to reach. • Fenbendazole and Mebendazole may interfere with tumor energy pathways. • Drug resistance could potentially be reduced. • Tumor shrinkage has been reported in difficult cases. The conversation around Anti-parasitic medicines is growing fast and patients need to know more. Follow us because we provide this type of information everyday! Visit our profile PharmacyinUSA to find these meds 🙌🏻 #Ivermectin #Fenbendazole #Mebendazole #Cancercure #MakisMD #PharmacyinUSA

PharmacyinUSA

20,889 просмотров • 5 месяцев назад

🚨 DR. WILLIAM MAKIS MD DISCUSSES CASTOR OIL + IVERMECTIN CREAM: WHY THIS TOPICAL COMBINATION IS GETTING ATTENTION A simple topical routine is creating a much bigger conversation online. 🫙 Castor oil 🧴 Ivermectin cream The video describes applying castor oil to several areas around the body's lymphatic system: • Under the armpits • Behind the ears • Along the jawline • Behind the knees The speaker says castor oil contains ricinoleic acid, which he says supports circulation and gentle lymphatic drainage. He also claims these applications can help with: • Bloating • Puffiness around the face • A heavy feeling in the legs • Dark buildup and odor under the arms Dr. William Makis MD discusses combining topical castor oil + Ivermectin cream in relation to: • Breast cancer • Head and neck cancer • Skin cancer 📌 THE TOPICAL ROUTINE 🫙 Gently massage organic cold pressed castor oil into areas around the lymph nodes. 🧴 Apply topical Ivermectin cream over the area. 📅 Continue for several days. The video also discusses reports of people using this combination who say they noticed: • Tighter feeling skin • Fine lines appearing reduced • Lymph swelling easing • Joint aches easing • Better sleep • Liver spots becoming lighter • Nerve pain easing • Nerve discomfort improving • Constipation clearing That's why this combination has caught people's attention. It's not simply another castor oil routine. It's the combination of castor oil + topical Ivermectin and the claims surrounding its potential use in cancer related discussions that are driving the conversation. The broader question is even bigger: Could inexpensive, existing medicines and familiar compounds have applications beyond their traditional uses? That's exactly why Ivermectin and drug repurposing continue to generate intense discussion online. 📌 Save this if you're following Ivermectin, castor oil, and cancer repurposing discussions. 🔄 Repost it so more people can discover the topical combination being discussed. 💊 Looking for Ivermectin cream or other repurposed medicines? Explore RXMEDS.STORE. #Ivermectin #CastorOil #WilliamMakis #BreastCancer #SkinCancer #CancerResearch #DrugRepurposing #MedicalResearch
0:46

🚨 DR. WILLIAM MAKIS MD DISCUSSES CASTOR OIL + IVERMECTIN CREAM: WHY THIS TOPICAL COMBINATION IS GETTING ATTENTION A simple topical routine is creating a much bigger conversation online. 🫙 Castor oil 🧴 Ivermectin cream The video describes applying castor oil to several areas around the body's lymphatic system: • Under the armpits • Behind the ears • Along the jawline • Behind the knees The speaker says castor oil contains ricinoleic acid, which he says supports circulation and gentle lymphatic drainage. He also claims these applications can help with: • Bloating • Puffiness around the face • A heavy feeling in the legs • Dark buildup and odor under the arms Dr. William Makis MD discusses combining topical castor oil + Ivermectin cream in relation to: • Breast cancer • Head and neck cancer • Skin cancer 📌 THE TOPICAL ROUTINE 🫙 Gently massage organic cold pressed castor oil into areas around the lymph nodes. 🧴 Apply topical Ivermectin cream over the area. 📅 Continue for several days. The video also discusses reports of people using this combination who say they noticed: • Tighter feeling skin • Fine lines appearing reduced • Lymph swelling easing • Joint aches easing • Better sleep • Liver spots becoming lighter • Nerve pain easing • Nerve discomfort improving • Constipation clearing That's why this combination has caught people's attention. It's not simply another castor oil routine. It's the combination of castor oil + topical Ivermectin and the claims surrounding its potential use in cancer related discussions that are driving the conversation. The broader question is even bigger: Could inexpensive, existing medicines and familiar compounds have applications beyond their traditional uses? That's exactly why Ivermectin and drug repurposing continue to generate intense discussion online. 📌 Save this if you're following Ivermectin, castor oil, and cancer repurposing discussions. 🔄 Repost it so more people can discover the topical combination being discussed. 💊 Looking for Ivermectin cream or other repurposed medicines? Explore RXMEDS.STORE. #Ivermectin #CastorOil #WilliamMakis #BreastCancer #SkinCancer #CancerResearch #DrugRepurposing #MedicalResearch

RXMEDS.STORE

124,126 просмотров • 1 месяц назад

🚨 “THEY CALLED IT HORSE PASTE… WHILE SCIENTISTS WERE STUDYING IT FOR CANCER AND CHEMO RESISTANCE.” That’s why the Ivermectin conversation refuses to die. According to researchers studying repurposed medicine, Ivermectin is one of the most fascinating molecules ever discovered because it appears to interact with completely different biological pathways depending on the disease being studied. In parasites, researchers found it affects chloride channels. In viruses, studies explored how it may interfere with replication pathways. And in cancer research, scientists have investigated how Ivermectin may interact with tumor proliferation pathways, cancer stem like cells, and chemotherapy resistance mechanisms. Researchers believe cancer stem cells may play a major role in: • Recurrence • Metastasis • Treatment resistance Traditional chemotherapy mainly targets rapidly dividing cells, but scientists are now studying whether Ivermectin may affect more resistant stem like cancer cells differently in laboratory settings. There are also preclinical studies investigating how Ivermectin may help restore chemotherapy sensitivity in resistant tumor cells at the molecular level. And then there’s another reason people keep talking about it: Some researchers have explored whether the same pathways involved in abnormal tumor growth may also be involved in conditions like fibroids, lipomas, and endometriosis. That’s why the repurposed medicine conversation has exploded far beyond COVID. If you’re researching Ivermectin, Fenbendazole, or Mebendazole, many choose PharmacyinUSA for worldwide and discreet delivery. #Ivermectin #HorseDewormer #CancerCure
3:28

🚨 “THEY CALLED IT HORSE PASTE… WHILE SCIENTISTS WERE STUDYING IT FOR CANCER AND CHEMO RESISTANCE.” That’s why the Ivermectin conversation refuses to die. According to researchers studying repurposed medicine, Ivermectin is one of the most fascinating molecules ever discovered because it appears to interact with completely different biological pathways depending on the disease being studied. In parasites, researchers found it affects chloride channels. In viruses, studies explored how it may interfere with replication pathways. And in cancer research, scientists have investigated how Ivermectin may interact with tumor proliferation pathways, cancer stem like cells, and chemotherapy resistance mechanisms. Researchers believe cancer stem cells may play a major role in: • Recurrence • Metastasis • Treatment resistance Traditional chemotherapy mainly targets rapidly dividing cells, but scientists are now studying whether Ivermectin may affect more resistant stem like cancer cells differently in laboratory settings. There are also preclinical studies investigating how Ivermectin may help restore chemotherapy sensitivity in resistant tumor cells at the molecular level. And then there’s another reason people keep talking about it: Some researchers have explored whether the same pathways involved in abnormal tumor growth may also be involved in conditions like fibroids, lipomas, and endometriosis. That’s why the repurposed medicine conversation has exploded far beyond COVID. If you’re researching Ivermectin, Fenbendazole, or Mebendazole, many choose PharmacyinUSA for worldwide and discreet delivery. #Ivermectin #HorseDewormer #CancerCure

PharmacyinUSA

15,939 просмотров • 3 месяцев назад

🚨 “THIS WAS NEVER SUPPOSED TO GO PUBLIC.” In a viral interview, William Makis claims cancer research missed something massive. But repurposed antiparasitics are hiding in plain sight. He says 👇 • Ivermectin targets cancer stem cells, chemo doesn’t touch • Fenbendazole and mebendazole disrupt tumor fuel pathways • Resistance may be reversed • Tumor shrinkage observed where nothing else worked Once you understand why these drugs are being studied, the next question is obvious. Where do you even get a clean, reliable supply? That’s why many independent researchers choose GENIX MEDS for ivermectin, fenbendazole, and mebendazole. Straightforward access. Affordable pricing. Worldwide delivery. #Ivermectin #Makismd #Cancercure #CancerAwareness
3:31

🚨 “THIS WAS NEVER SUPPOSED TO GO PUBLIC.” In a viral interview, William Makis claims cancer research missed something massive. But repurposed antiparasitics are hiding in plain sight. He says 👇 • Ivermectin targets cancer stem cells, chemo doesn’t touch • Fenbendazole and mebendazole disrupt tumor fuel pathways • Resistance may be reversed • Tumor shrinkage observed where nothing else worked Once you understand why these drugs are being studied, the next question is obvious. Where do you even get a clean, reliable supply? That’s why many independent researchers choose GENIX MEDS for ivermectin, fenbendazole, and mebendazole. Straightforward access. Affordable pricing. Worldwide delivery. #Ivermectin #Makismd #Cancercure #CancerAwareness

GENIX MEDS

244,318 просмотров • 7 месяцев назад

🚨 “MY GRANDMA’S BACK.” DR. WILLIAM MAKIS ON THE IVERMECTIN PROTOCOL HE REPORTS USING FOR NEUROLOGICAL CONDITIONS Most people know Ivermectin for its antiparasitic use. But Dr. William Makis says another area deserves far more attention: Neurological conditions. He specifically discusses Parkinson’s disease and Alzheimer’s disease, along with several other neurological conditions shown in the accompanying dosing graphic. 🧠 Parkinson’s disease Makis describes using high-dose Ivermectin and reports amounts around: 💊 60–72 mg/day Makis says patients experienced improvements in symptoms and movement. One patient, he says, was barely mobile despite maximum standard treatment. After several weeks, he says she was playing golf again. “And I've seen reversal in a number of Parkinson's disease patients.” 🧠 Alzheimer’s & dementia This is where Makis says the stories became even more striking. He describes reported amounts of: 💊 12 mg 💊 12–24 mg for several days According to his account, some families reported that elderly patients began: ✅ Recognizing relatives they hadn't recognized for years ✅ Remembering old experiences ✅ Reminiscing ✅ Showing improved cognitive ability Then comes the quote that stands out: “My grandma’s back.” Makis says families told him their loved ones had their memories and sense of humor back. He also describes one patient who, according to his account, was taken off hospice because of improvement. 📊 The reported neurological protocol The reported human neurological Ivermectin dosing across conditions including: • Parkinson’s disease • Parkinsonism • Alzheimer’s/dementia • Drug-resistant epilepsy • Neurocysticercosis • Huntington’s chorea • Tremor • Dystonia The video includes different reported dosing ranges and identifies different evidence types, from case reports and physician-reported cases to observational studies and clinical research. 🔥 But the most powerful part isn't the numbers It's what Makis says families describe afterward. “The moments that the family gets back are so precious.” ⁉️ Why this conversation matters From Parkinson’s and Alzheimer’s to epilepsy, tremor and dystonia, Makis says he has seen a much broader neurological side of Ivermectin than most people realize. For families facing neurological disease, even the possibility of better movement, clearer memories and more meaningful time with loved ones can mean everything. Ivermectin is now part of a much bigger neurological research conversation, and there is still much to explore. 📌 SAVE this breakdown and come back to it. 🔄 REPOST to help keep the neurological Ivermectin conversation moving. 💊 Looking for Ivermectin? Discover available options at RXMEDS.STORE with worldwide delivery. #Ivermectin #NeurologicalConditions #Parkinsons #Alzheimers #Dementia #Neurology #RepurposedMedicine #MedicalResearch
4:02

🚨 “MY GRANDMA’S BACK.” DR. WILLIAM MAKIS ON THE IVERMECTIN PROTOCOL HE REPORTS USING FOR NEUROLOGICAL CONDITIONS Most people know Ivermectin for its antiparasitic use. But Dr. William Makis says another area deserves far more attention: Neurological conditions. He specifically discusses Parkinson’s disease and Alzheimer’s disease, along with several other neurological conditions shown in the accompanying dosing graphic. 🧠 Parkinson’s disease Makis describes using high-dose Ivermectin and reports amounts around: 💊 60–72 mg/day Makis says patients experienced improvements in symptoms and movement. One patient, he says, was barely mobile despite maximum standard treatment. After several weeks, he says she was playing golf again. “And I've seen reversal in a number of Parkinson's disease patients.” 🧠 Alzheimer’s & dementia This is where Makis says the stories became even more striking. He describes reported amounts of: 💊 12 mg 💊 12–24 mg for several days According to his account, some families reported that elderly patients began: ✅ Recognizing relatives they hadn't recognized for years ✅ Remembering old experiences ✅ Reminiscing ✅ Showing improved cognitive ability Then comes the quote that stands out: “My grandma’s back.” Makis says families told him their loved ones had their memories and sense of humor back. He also describes one patient who, according to his account, was taken off hospice because of improvement. 📊 The reported neurological protocol The reported human neurological Ivermectin dosing across conditions including: • Parkinson’s disease • Parkinsonism • Alzheimer’s/dementia • Drug-resistant epilepsy • Neurocysticercosis • Huntington’s chorea • Tremor • Dystonia The video includes different reported dosing ranges and identifies different evidence types, from case reports and physician-reported cases to observational studies and clinical research. 🔥 But the most powerful part isn't the numbers It's what Makis says families describe afterward. “The moments that the family gets back are so precious.” ⁉️ Why this conversation matters From Parkinson’s and Alzheimer’s to epilepsy, tremor and dystonia, Makis says he has seen a much broader neurological side of Ivermectin than most people realize. For families facing neurological disease, even the possibility of better movement, clearer memories and more meaningful time with loved ones can mean everything. Ivermectin is now part of a much bigger neurological research conversation, and there is still much to explore. 📌 SAVE this breakdown and come back to it. 🔄 REPOST to help keep the neurological Ivermectin conversation moving. 💊 Looking for Ivermectin? Discover available options at RXMEDS.STORE with worldwide delivery. #Ivermectin #NeurologicalConditions #Parkinsons #Alzheimers #Dementia #Neurology #RepurposedMedicine #MedicalResearch

RXMEDS.STORE

22,574 просмотров • 1 день назад

🚨 76-YEAR-OLD WITH GLEASON 7 PROSTATE CANCER TAKES IVERMECTIN. 12 WEEKS LATER, PET SCAN SHOWS NOTHING. A doctor shared the story of a 76-year-old veteran who had been diagnosed with Gleason 7 prostate cancer. According to the doctor, the patient began taking 12 mg of Ivermectin daily. After eight weeks, he continued with follow-up testing. At around 12 weeks, he underwent a specialized PET scan looking for abnormalities associated with the prostate. The doctor says the scan could no longer find the cancerous abnormalities. There was another change too. His PSA, which had been 12.6 when the cancer was initially diagnosed, had dropped to 5.3. That is a significant change in the numbers the doctor shared. The story raises an obvious question about the potential role of Ivermectin in prostate cancer, particularly given the growing interest in repurposing older medicines for oncology. Ivermectin is already well established as an antiparasitic medicine, while research into its potential anticancer effects continues to explore mechanisms involving cancer cell growth, survival and signaling. Could Ivermectin deserve a closer look in prostate cancer research?
0:48

🚨 76-YEAR-OLD WITH GLEASON 7 PROSTATE CANCER TAKES IVERMECTIN. 12 WEEKS LATER, PET SCAN SHOWS NOTHING. A doctor shared the story of a 76-year-old veteran who had been diagnosed with Gleason 7 prostate cancer. According to the doctor, the patient began taking 12 mg of Ivermectin daily. After eight weeks, he continued with follow-up testing. At around 12 weeks, he underwent a specialized PET scan looking for abnormalities associated with the prostate. The doctor says the scan could no longer find the cancerous abnormalities. There was another change too. His PSA, which had been 12.6 when the cancer was initially diagnosed, had dropped to 5.3. That is a significant change in the numbers the doctor shared. The story raises an obvious question about the potential role of Ivermectin in prostate cancer, particularly given the growing interest in repurposing older medicines for oncology. Ivermectin is already well established as an antiparasitic medicine, while research into its potential anticancer effects continues to explore mechanisms involving cancer cell growth, survival and signaling. Could Ivermectin deserve a closer look in prostate cancer research?

Joe Tippens

39,275 просмотров • 1 месяц назад

After a year of intensive research, Dr. William Makis presents the most crucial graph of his career: the ivermectin dosing schedule for cancer. Dr. Makis recommends a starting dose of 1mg per kg of body weight per day for most cancers, including breast, colon, lung, pancreatic, renal, gastric, and leukemias. For a 60kg individual, this translates to 60mg daily, which can be taken as: - Five 12mg pills - Or 6ml of liquid (approximately one teaspoon plus 1ml) The evidence supporting the efficacy of ivermectin is compelling and dose-dependent. - Dr. Shankara Chetty observed a significant drop in a prostate cancer patient’s PSA from 89 to 11 after taking 45mg/day. - Dr. Tess Lawry’s case study showed a remarkable decrease in CA125 (an ovarian cancer marker) from 288 to 22 after just 0.2mg/kg. - A long-term Castro study on children with leukemia demonstrated no side effects after 6 months at a dose of 1mg/kg. For aggressive cancers like pancreatic and brain cancers, a higher dose may be necessary due to the blood-brain barrier. Dr. Makis cites examples: - Dr. Landrito’s colleague with terminal gallbladder cancer experienced the disappearance of cancer after 14 months at a dose of 2mg/kg/day. - The highest documented dose is 2.5mg/kg, as reported by Dr. Chetty, with only transient visual side effects that resolved. Mainstream oncology is unlikely to offer this treatment due to ivermectin’s generic, off-patent status and unprofitable nature. Consequently, there are no funded clinical trials. Dr. Makis concludes that using ivermectin in cancer treatment is straightforward and highly safe. He strongly suggests that those struggling with cancer should start with a dose of 1mg/kg/day. This can be taken for several months, even over a year, with an excellent safety profile based on long-term anecdotal evidence. The power to fight cancer may already be within your reach.
5:47

After a year of intensive research, Dr. William Makis presents the most crucial graph of his career: the ivermectin dosing schedule for cancer. Dr. Makis recommends a starting dose of 1mg per kg of body weight per day for most cancers, including breast, colon, lung, pancreatic, renal, gastric, and leukemias. For a 60kg individual, this translates to 60mg daily, which can be taken as: - Five 12mg pills - Or 6ml of liquid (approximately one teaspoon plus 1ml) The evidence supporting the efficacy of ivermectin is compelling and dose-dependent. - Dr. Shankara Chetty observed a significant drop in a prostate cancer patient’s PSA from 89 to 11 after taking 45mg/day. - Dr. Tess Lawry’s case study showed a remarkable decrease in CA125 (an ovarian cancer marker) from 288 to 22 after just 0.2mg/kg. - A long-term Castro study on children with leukemia demonstrated no side effects after 6 months at a dose of 1mg/kg. For aggressive cancers like pancreatic and brain cancers, a higher dose may be necessary due to the blood-brain barrier. Dr. Makis cites examples: - Dr. Landrito’s colleague with terminal gallbladder cancer experienced the disappearance of cancer after 14 months at a dose of 2mg/kg/day. - The highest documented dose is 2.5mg/kg, as reported by Dr. Chetty, with only transient visual side effects that resolved. Mainstream oncology is unlikely to offer this treatment due to ivermectin’s generic, off-patent status and unprofitable nature. Consequently, there are no funded clinical trials. Dr. Makis concludes that using ivermectin in cancer treatment is straightforward and highly safe. He strongly suggests that those struggling with cancer should start with a dose of 1mg/kg/day. This can be taken for several months, even over a year, with an excellent safety profile based on long-term anecdotal evidence. The power to fight cancer may already be within your reach.

Commentary | Global Ivermectin Research Hub

102,157 просмотров • 5 месяцев назад

🚨 DR. WILLIAM MAKIS’ IVERMECTIN DOSING GUIDE FOR CANCER & PREVENTION IS SPREADING FAST ONLINE Thousands are now discussing Dr. William Makis MD’s categorized Ivermectin dosing approach based on body weight (mg/kg/day) and cancer severity. Here’s the breakdown people keep sharing: LOW DOSE: ≤ 0.5 mg/kg/day Often discussed for: • Remission support • Prevention strategies • Strong family cancer history ⚠️ Reports shared online describe minimal long term side effects at lower ranges. Access them via PharmacyinUSA MEDIUM DOSE: 1.0 mg/kg/day Most commonly discussed for: • Breast cancer • Lung cancer • Colon cancer • Pancreatic cancer • Renal cancers ⚠️ Supporters claim this is the “standard starting range” used in many repurposed drug discussions. HIGH DOSE: 2.0 mg/kg/day Typically discussed for: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers ⚠️ Some anecdotal reports mention temporary visual side effects at higher dosing ranges. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Usually discussed only for: • Advanced metastatic disease • Late stage aggressive cancers ⚠️ High dose use remains highly controversial and experimental. Quick weight example for a 60 kg (132 lb) adult: • Low: 30 mg/day • Medium: 60 mg/day • High: 120 mg/day • Very High: 150+ mg/day Why this conversation keeps exploding online: ✅ Ivermectin has decades of human use worldwide ✅ Growing interest in repurposed cancer drugs ✅ Observational and preclinical research continues expanding ✅ Patients are increasingly sharing personal experiences publicly. (Jase Medical) Still, millions are now asking why inexpensive repurposed drugs are generating so much public interest while receiving so little mainstream discussion. **The chart has been upscaled for better visibility** #Ivermectin #Fenbendazole #Mebendazole
5:52

🚨 DR. WILLIAM MAKIS’ IVERMECTIN DOSING GUIDE FOR CANCER & PREVENTION IS SPREADING FAST ONLINE Thousands are now discussing Dr. William Makis MD’s categorized Ivermectin dosing approach based on body weight (mg/kg/day) and cancer severity. Here’s the breakdown people keep sharing: LOW DOSE: ≤ 0.5 mg/kg/day Often discussed for: • Remission support • Prevention strategies • Strong family cancer history ⚠️ Reports shared online describe minimal long term side effects at lower ranges. Access them via PharmacyinUSA MEDIUM DOSE: 1.0 mg/kg/day Most commonly discussed for: • Breast cancer • Lung cancer • Colon cancer • Pancreatic cancer • Renal cancers ⚠️ Supporters claim this is the “standard starting range” used in many repurposed drug discussions. HIGH DOSE: 2.0 mg/kg/day Typically discussed for: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers ⚠️ Some anecdotal reports mention temporary visual side effects at higher dosing ranges. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Usually discussed only for: • Advanced metastatic disease • Late stage aggressive cancers ⚠️ High dose use remains highly controversial and experimental. Quick weight example for a 60 kg (132 lb) adult: • Low: 30 mg/day • Medium: 60 mg/day • High: 120 mg/day • Very High: 150+ mg/day Why this conversation keeps exploding online: ✅ Ivermectin has decades of human use worldwide ✅ Growing interest in repurposed cancer drugs ✅ Observational and preclinical research continues expanding ✅ Patients are increasingly sharing personal experiences publicly. (Jase Medical) Still, millions are now asking why inexpensive repurposed drugs are generating so much public interest while receiving so little mainstream discussion. **The chart has been upscaled for better visibility** #Ivermectin #Fenbendazole #Mebendazole

PharmacyinUSA

91,070 просмотров • 4 месяцев назад

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.
9:41

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

Bobby

160,046 просмотров • 1 год назад

🚨IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION Based on Dr. William Makis MD's commonly shared dosing framework Thousands of people reference this ivermectin dosing chart. Below is a simplified breakdown organized by body weight (mg/kg per day). 📌LOW DOSE ≤ 0.5 mg/kg/day Best For: • Cancers in remission • Strong family history or genetic predisposition • Preventive (prophylactic) use Reported Side Effects: • No long-term side effects reported Example: Dr. Tess Lawrie reported a Stage 3 ovarian cancer patient who received chemotherapy plus 12 mg ivermectin daily. After 2 months, the tumor marker CA125 fell from 288 to 22, and the tumor was reported to have disappeared. 📌MEDIUM DOSE 1.0 mg/kg/day Best For: • Starting dose for many cancers including: • Lung cancer • Pancreatic cancer • Renal cell carcinoma • Gastric cancer Reported Side Effects: • No long-term side effects reported Example: Dr. Shankara Chetty reported a 70-year-old prostate cancer patient with a PSA of 89 taking 45 mg daily (along with lactoferrin). After 2 months, PSA reportedly decreased to 10.9. 📌HIGH DOSE 2.0 mg/kg/day Best For: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers Reported Side Effects: • No long-term side effects reported Example: Dr. Allan Landrito reported a Stage 4 gallbladder cancer patient taking 2 mg/kg daily for 14 months, with the cancer reportedly disappearing. 📌VERY HIGH DOSE ≥ 2.5 mg/kg/day Best For: • Extensive metastatic disease • Extremely poor prognosis • Certain aggressive brain cancers Possible Side Effects: • Temporary visual disturbances • Usually, short lived and resolve within days Example: Dr. Shankara Chetty reported using 2.5 mg/kg/day in a patient with no side effects reported. #Ivermectin #MakisMD #Genixmeds
5:47

🚨IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION Based on Dr. William Makis MD's commonly shared dosing framework Thousands of people reference this ivermectin dosing chart. Below is a simplified breakdown organized by body weight (mg/kg per day). 📌LOW DOSE ≤ 0.5 mg/kg/day Best For: • Cancers in remission • Strong family history or genetic predisposition • Preventive (prophylactic) use Reported Side Effects: • No long-term side effects reported Example: Dr. Tess Lawrie reported a Stage 3 ovarian cancer patient who received chemotherapy plus 12 mg ivermectin daily. After 2 months, the tumor marker CA125 fell from 288 to 22, and the tumor was reported to have disappeared. 📌MEDIUM DOSE 1.0 mg/kg/day Best For: • Starting dose for many cancers including: • Lung cancer • Pancreatic cancer • Renal cell carcinoma • Gastric cancer Reported Side Effects: • No long-term side effects reported Example: Dr. Shankara Chetty reported a 70-year-old prostate cancer patient with a PSA of 89 taking 45 mg daily (along with lactoferrin). After 2 months, PSA reportedly decreased to 10.9. 📌HIGH DOSE 2.0 mg/kg/day Best For: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers Reported Side Effects: • No long-term side effects reported Example: Dr. Allan Landrito reported a Stage 4 gallbladder cancer patient taking 2 mg/kg daily for 14 months, with the cancer reportedly disappearing. 📌VERY HIGH DOSE ≥ 2.5 mg/kg/day Best For: • Extensive metastatic disease • Extremely poor prognosis • Certain aggressive brain cancers Possible Side Effects: • Temporary visual disturbances • Usually, short lived and resolve within days Example: Dr. Shankara Chetty reported using 2.5 mg/kg/day in a patient with no side effects reported. #Ivermectin #MakisMD #Genixmeds

GENIX MEDS

31,415 просмотров • 3 месяцев назад

🚨 WHY IVERMECTIN DOSING ISN'T ONE SIZE FITS ALL. THIS PHYSICIAN EXPLAINS THE DIFFERENCE. A physician starts with a point that many people overlook: Ivermectin dosing is weight based. So before discussing any amount, she starts with body weight. 📌 Her conversion: Weight in pounds ÷ 2.2 = kilograms Her example: 130 lb ÷ 2.2 ≈ 59 kg But that's only the starting point. She then explains that the amount she discusses changes depending on what Ivermectin is being used for. 💊 PREVENTION 0.2 mg/kg twice a week 💊 PARASITE CLEANSE 0.3 mg/kg She says she then follows the protocol associated with her parasite cleanse. 💊 COVID, FLU OR RSV She describes a range of: 0.4 to 0.6 mg/kg She also explains that she may round the calculated amount upward to an even 5 mg increment. Then comes the most variable category. 💊 CANCER She says the amount can depend on: • Cancer type • Cancer stage • Disease progression • How aggressive the approach is She says she may go as high as: 📈 1 mg/kg or higher Then she gives the principle behind her entire explanation: "It just depends on what you're doing it for." And the lowest amount she says she would use? 📌 0.2 mg/kg But the bigger takeaway from this discussion is simple: Ivermectin dosing depends on what it is being used for, not just body weight. And simply converting pounds to kilograms and applying a number isn't enough to determine an appropriate treatment plan. Indication, formulation, other medications, medical history, and safety all matter. Ivermectin has a long history of human use, but higher doses can increase the risk of adverse effects. The FDA also distinguishes human ivermectin products from veterinary formulations, which are not substitutes for medicines intended for people. And when the indication is experimental, particularly cancer, the dosing question is something clinical research still needs to answer. 📌 Save this post if you're researching Ivermectin dosing and want to understand why there isn't one universal number. 🔄 Repost it so others researching Ivermectin can see the discussion. 💊 Exploring Ivermectin? See why thousands of customers worldwide choose RXMEDS.STORE for pharmaceutical grade Ivermectin. #Ivermectin #IvermectinDosage #IvermectinResearch #RepurposedDrugs #MedicalResearch
1:42

🚨 WHY IVERMECTIN DOSING ISN'T ONE SIZE FITS ALL. THIS PHYSICIAN EXPLAINS THE DIFFERENCE. A physician starts with a point that many people overlook: Ivermectin dosing is weight based. So before discussing any amount, she starts with body weight. 📌 Her conversion: Weight in pounds ÷ 2.2 = kilograms Her example: 130 lb ÷ 2.2 ≈ 59 kg But that's only the starting point. She then explains that the amount she discusses changes depending on what Ivermectin is being used for. 💊 PREVENTION 0.2 mg/kg twice a week 💊 PARASITE CLEANSE 0.3 mg/kg She says she then follows the protocol associated with her parasite cleanse. 💊 COVID, FLU OR RSV She describes a range of: 0.4 to 0.6 mg/kg She also explains that she may round the calculated amount upward to an even 5 mg increment. Then comes the most variable category. 💊 CANCER She says the amount can depend on: • Cancer type • Cancer stage • Disease progression • How aggressive the approach is She says she may go as high as: 📈 1 mg/kg or higher Then she gives the principle behind her entire explanation: "It just depends on what you're doing it for." And the lowest amount she says she would use? 📌 0.2 mg/kg But the bigger takeaway from this discussion is simple: Ivermectin dosing depends on what it is being used for, not just body weight. And simply converting pounds to kilograms and applying a number isn't enough to determine an appropriate treatment plan. Indication, formulation, other medications, medical history, and safety all matter. Ivermectin has a long history of human use, but higher doses can increase the risk of adverse effects. The FDA also distinguishes human ivermectin products from veterinary formulations, which are not substitutes for medicines intended for people. And when the indication is experimental, particularly cancer, the dosing question is something clinical research still needs to answer. 📌 Save this post if you're researching Ivermectin dosing and want to understand why there isn't one universal number. 🔄 Repost it so others researching Ivermectin can see the discussion. 💊 Exploring Ivermectin? See why thousands of customers worldwide choose RXMEDS.STORE for pharmaceutical grade Ivermectin. #Ivermectin #IvermectinDosage #IvermectinResearch #RepurposedDrugs #MedicalResearch

RXMEDS.STORE

33,968 просмотров • 1 месяц назад

🚨 WHY IS CASTOR OIL + IVERMECTIN GETTING SO MUCH ATTENTION? A simple combination is showing up in a growing number of online discussions: Castor oil + Topical Ivermectin. Dr. William Makis has discussed this combination in connection with topical routines and conversations surrounding breast cancer, head and neck cancer, and skin cancer. The idea goes beyond just using Ivermectin as an anti-parasitic. The combination being discussed Castor oil is typically applied topically around areas such as: • Under the arms • Behind the ears • Along the jawline • Behind the knees The discussion centers on castor oil's ricinoleic acid content and claims around circulation and lymphatic drainage. Topical Ivermectin came into the conversation just because of its established efficacy against certain parasites and its dermatological use. 🤔 Why Ivermectin stands out Ivermectin isn't just an internet trend. 1% topical Ivermectin is an FDA-approved treatment for inflammatory rosacea, with clinical trials showing improvement compared with vehicle cream. At the same time, researchers have been investigating Ivermectin's potential for drug repurposing in cancer. Laboratory and animal studies have reported anticancer activity across several cancer models, even though the human clinical evidence remains limited. That's where the Castor oil + Ivermectin conversation becomes particularly interesting. People are asking whether familiar, inexpensive compounds might have applications beyond their traditional uses. 📲 What people are reporting online Supporters of the routine have described experiences involving: • Less puffiness • Changes in skin appearance • Reduced feelings of swelling • Improved sleep • Changes in nerve discomfort • Changes in joint discomfort These are reported experiences, not established outcomes of the combination. But they're also part of the reason why the discussion keeps spreading. ✅ Castor oil ✅ Ivermectin ✅ Drug repurposing. Three familiar topics coming together in one increasingly discussed routine. 🔁 If you're following the growing Ivermectin conversation, save this post and share it with someone who has been researching topical Ivermectin. Looking for Ivermectin cream? Explore options through PharmacyinUSA, with worldwide delivery. #Ivermectin #CastorOil #WilliamMakis #IvermectinCream #CancerResearch #Rosacea #SkinHealth #PharmacyinUSA
0:46

🚨 WHY IS CASTOR OIL + IVERMECTIN GETTING SO MUCH ATTENTION? A simple combination is showing up in a growing number of online discussions: Castor oil + Topical Ivermectin. Dr. William Makis has discussed this combination in connection with topical routines and conversations surrounding breast cancer, head and neck cancer, and skin cancer. The idea goes beyond just using Ivermectin as an anti-parasitic. The combination being discussed Castor oil is typically applied topically around areas such as: • Under the arms • Behind the ears • Along the jawline • Behind the knees The discussion centers on castor oil's ricinoleic acid content and claims around circulation and lymphatic drainage. Topical Ivermectin came into the conversation just because of its established efficacy against certain parasites and its dermatological use. 🤔 Why Ivermectin stands out Ivermectin isn't just an internet trend. 1% topical Ivermectin is an FDA-approved treatment for inflammatory rosacea, with clinical trials showing improvement compared with vehicle cream. At the same time, researchers have been investigating Ivermectin's potential for drug repurposing in cancer. Laboratory and animal studies have reported anticancer activity across several cancer models, even though the human clinical evidence remains limited. That's where the Castor oil + Ivermectin conversation becomes particularly interesting. People are asking whether familiar, inexpensive compounds might have applications beyond their traditional uses. 📲 What people are reporting online Supporters of the routine have described experiences involving: • Less puffiness • Changes in skin appearance • Reduced feelings of swelling • Improved sleep • Changes in nerve discomfort • Changes in joint discomfort These are reported experiences, not established outcomes of the combination. But they're also part of the reason why the discussion keeps spreading. ✅ Castor oil ✅ Ivermectin ✅ Drug repurposing. Three familiar topics coming together in one increasingly discussed routine. 🔁 If you're following the growing Ivermectin conversation, save this post and share it with someone who has been researching topical Ivermectin. Looking for Ivermectin cream? Explore options through PharmacyinUSA, with worldwide delivery. #Ivermectin #CastorOil #WilliamMakis #IvermectinCream #CancerResearch #Rosacea #SkinHealth #PharmacyinUSA

PharmacyinUSA

116,820 просмотров • 1 день назад